In a groundbreaking study, scientists at the University of Zurich have successfully reversed stroke-induced damage in mice using human neural stem cells, successfully regenerating neurons, restoring blood vessels, and even restoring motor function.
These lab-grown cells were transplanted a week after a stroke and not only integrated into existing neural networks in the brain but also triggered a series of regenerative effects, including reduced inflammation and improved blood-brain barrier integrity.
The treated mice showed motor recovery, verified by artificial intelligence-assisted gait analysis, offering new hope for the millions of people with long-term disabilities after strokes.
Importantly, the research used human induced pluripotent stem cells, which were prepared without the use of animal-source materials, bringing the treatment one step closer to clinical application. The delayed transplantation timing seven days after a stroke could simplify human applications by giving doctors more time to prepare the treatment. While safety measures, such as cell growth control and non-invasive delivery methods, are still under development, these findings represent an important step toward potential treatments for restoring function in stroke patients in humans. As trials of cell-based therapies for diseases like Parkinson's begin, trials for stroke treatment may soon follow.
At the I.D. Stem Cells and Genome Institute, we keep up with the latest developments in stem cell and gene therapy and regenerative medicine. If you are interested in learning more about the potential benefits of these treatments and the latest research findings, please feel free to contact us.
